New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”

Thumbnail
View/Open
Issue date
2020
Author
de Hollanda, Ana
Lecube Torelló, Albert
Rubio, Miguel Ángel
Sánchez Peña, Enric
Vilarrasa, Núria
Gregorio Oliva, José
Fernández-Soto, María Luisa
Salas-Salvadó, Jordi
Ballesteros-Pomar, María D.
Ciudin, Andreea
Torres, Ferran
Vidal, Concepción
Morales, María José
Valdés, Sergio
Pellitero, Silvia
Miñambres, Inka
Masmiquel, Lluís
Goday, Albert
Suarez, Lorena
Flores, Liliam
Bueno Díez, Marta
Caixàs, Assumpta
Bretón, Irene
Cámara, Rosa
Olbeyra, Romina
Penso, Rona
de la Cruz, María José
Simó-Servat, Andreu
Pereyra-García, Francisca María
López-Mezquita, Elena Teresa
Gils, Anna
Fidilio, Enzamaria
Bandrés, Orosia
Martínez, Ángel
Abuín, Jose
Marques-Pamies, Montserrat
Tuneu, Laura
Arteaga, Magdalena
Castañer, Olga
Goñi, Fernando
Arrizabalaga, Cristina
Botana, Manuel Antonio
Calañas, Alfonso
Suggested citation
de Hollanda, Ana; Lecube Torelló, Albert; Rubio, Miguel Ángel; Sánchez Peña, Enric; Vilarrasa, Núria; Gregorio Oliva, José; ... Calañas, Alfonso. (2020) . New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”. Journal of Clinical Medicine, 2020, vol. 9, núm. 4, p. 1070. https://doi.org/10.3390/jcm9041070.
Impact

Google Scholar logo  Google Scholar
Share
Export to Mendeley
Metadata
Show full item record
Abstract
Almost one third of patients do not achieve type 2 diabetes remission after bariatric surgery or are unable to sustain this effect long term. Our objective was to delve further into the dynamic responses of diabetes after bariatric surgery and to evaluate the “time-within-remission range” as a variable of metabolic control. A descriptive cohort study was done using a computerised multicentre and multidisciplinary registry. All data were adjusted by propensity score. A total of 1186 subjects with a follow-up of 4.5 ± 2.5 years were included. Type of surgery, diabetes remission, recurrence of diabetes, “time-within-remission range” and key predictors of diabetes outcomes were assessed. All patients (70% women, 51.4 ± 9.2 years old, body mass index (BMI) 46.3 ± 6.9 kg/m2 ) underwent primary bariatric procedures. “Time-within-remission range” were 83.3% (33.3–91.6) after gastric bypass, 68.7% (7.1–87.5) after sleeve gastrectomy and 90% (83.3–92.8) after malabsorptive techniques (p < 0.001 for all). Duration of diabetes, baseline HbA1c and insulin treatment were significantly negatively correlated with the “time-within-remission range”. The association of bariatric techniques with “time-within-remission range”, using gastric bypass as a reference, were: odds ratio (OR) 3.70 (2.34–5.84), p < 0.001 for malabsorptive techniques and OR 0.55 (0.40–0.75), p < 0.001 for sleeve gastrectomy. Characteristics of type 2 diabetes powerfully influence the outcomes of bariatric surgery. The “time-within-remission range” unveils a superiority of gastric bypass compared to sleeve gastrectomy
URI
http://hdl.handle.net/10459.1/69595
DOI
https://doi.org/10.3390/jcm9041070
Is part of
Journal of Clinical Medicine, 2020, vol. 9, núm. 4, p. 1070
Collections

The following license files are associated with this item:

cc-by (c) de Hollanda, Ana et al., 2020
Except where otherwise noted, this item's license is described as cc-by (c) de Hollanda, Ana et al., 2020